Association between B-lines on lung ultrasound, invasive haemodynamics, and prognosis in acute heart failure patients.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
09 Feb 2023
Historique:
received: 01 09 2022
revised: 05 12 2022
accepted: 21 12 2022
pubmed: 23 12 2022
medline: 14 2 2023
entrez: 22 12 2022
Statut: ppublish

Résumé

Increased left atrial pressure leads to pulmonary congestion. Although the B-lines in lung ultrasound (LUS) are useful in detecting pulmonary congestion, data regarding the association between B-lines and invasive haemodynamics are inconsistent. This study aimed to explore the correlation of the B-line count by LUS with pulmonary capillary wedge pressure (PCWP) stratified for preserved and reduced ejection fraction (EF) in acute heart failure patients. We performed a prospective observational study on 116 hospitalized patients with acute heart failure (mean age, 75.2 ± 10.3 years), who underwent right heart catheterization before discharge. LUS was performed in eight zones within 4 h of right heart catheterization and compared with PCWP separately in each EF group. Cardiac events were recorded 1 year after discharge. PCWP revealed a clear pivot point at which the B-lines began to increase in the overall cohort and each EF. Specific thresholds of the increase in B-lines were identified at 19 and 25 mmHg for preserved and reduced EF, respectively. Residual congestion at discharge was defined as the presence of ≥6 B-lines. Patients with residual congestion had a higher risk for cardiac events than those without residual congestion (hazard ratio, 12.6; 95% confidence interval, 4.71-33.7; log-rank, P < 0.0001). A clear pivot point was associated with increased B-lines count in PCWP at 19 and 25 mmHg for preserved and reduced EF, respectively. Moreover, the increased B-line count above the defined cut-off used to quantify residual congestion was associated with significantly worse outcomes.

Identifiants

pubmed: 36548965
pii: 6957333
doi: 10.1093/ehjacc/zuac158
pmc: PMC9910565
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115-123

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.

Déclaration de conflit d'intérêts

Conflict of interest: None declared.

Références

Eur J Heart Fail. 2019 Jul;21(7):844-851
pubmed: 31218825
J Am Coll Cardiol. 2014 Apr 1;63(12):1123-1133
pubmed: 24491689
J Am Soc Echocardiogr. 2006 Mar;19(3):356-63
pubmed: 16500505
ESC Heart Fail. 2021 Jun;8(3):1759-1766
pubmed: 33704921
Eur J Heart Fail. 2013 Apr;15(4):368-75
pubmed: 23248216
Cardiovasc Res. 2001 Jan;49(1):207-17
pubmed: 11121813
Anesthesiology. 2014 Aug;121(2):320-7
pubmed: 24821071
Circ Res. 1962 Dec;11:966-70
pubmed: 13995239
Circulation. 1995 Aug 1;92(3):622-31
pubmed: 7634477
Intensive Care Med. 2012 Apr;38(4):577-91
pubmed: 22392031
Eur J Heart Fail. 2012 Nov;14(11):1276-84
pubmed: 22962280
Eur Respir Rev. 2009 Dec;18(114):244-52
pubmed: 20956149
Eur Heart J. 2016 Apr 14;37(15):1244-51
pubmed: 26819225
Int J Cardiol. 2019 Apr 15;281:62-68
pubmed: 30718133
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
J Physiol. 1896 May 5;19(4):312-26
pubmed: 16992325
Circ Res. 1959 Jul;7(4):649-57
pubmed: 13663218
Physiol Rev. 2002 Jul;82(3):569-600
pubmed: 12087129
Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1321-1360
pubmed: 27422899
J Am Coll Cardiol. 2009 Apr 14;53(15):e1-e90
pubmed: 19358937
Lancet. 2018 Feb 10;391(10120):572-580
pubmed: 29174292

Auteurs

Junichi Imanishi (J)

Department of Cardiology, Hyogo Prefectural Awaji Medicine Center, 1-1-137, Shioya, Sumoto-shi, Hyogo 656-0021, Japan.

Takanori Maeda (T)

Department of Cardiology, Hyogo Prefectural Awaji Medicine Center, 1-1-137, Shioya, Sumoto-shi, Hyogo 656-0021, Japan.

Sae Ujiro (S)

Department of Cardiology, Hyogo Prefectural Awaji Medicine Center, 1-1-137, Shioya, Sumoto-shi, Hyogo 656-0021, Japan.

Mayuka Masuda (M)

Department of Cardiology, Hyogo Prefectural Awaji Medicine Center, 1-1-137, Shioya, Sumoto-shi, Hyogo 656-0021, Japan.

Yuta Kusakabe (Y)

Department of Cardiology, Hyogo Prefectural Awaji Medicine Center, 1-1-137, Shioya, Sumoto-shi, Hyogo 656-0021, Japan.

Makoto Takemoto (M)

Department of Cardiology, Hyogo Prefectural Awaji Medicine Center, 1-1-137, Shioya, Sumoto-shi, Hyogo 656-0021, Japan.

Wataru Fujimoto (W)

Department of Cardiology, Hyogo Prefectural Awaji Medicine Center, 1-1-137, Shioya, Sumoto-shi, Hyogo 656-0021, Japan.

Koji Kuroda (K)

Department of Cardiology, Hyogo Prefectural Awaji Medicine Center, 1-1-137, Shioya, Sumoto-shi, Hyogo 656-0021, Japan.

Soichiro Yamashita (S)

Department of Cardiology, Hyogo Prefectural Awaji Medicine Center, 1-1-137, Shioya, Sumoto-shi, Hyogo 656-0021, Japan.

Masamichi Iwasaki (M)

Department of Cardiology, Hyogo Prefectural Awaji Medicine Center, 1-1-137, Shioya, Sumoto-shi, Hyogo 656-0021, Japan.

Takahumi Todoroki (T)

Department of Cardiology, Hyogo Prefectural Awaji Medicine Center, 1-1-137, Shioya, Sumoto-shi, Hyogo 656-0021, Japan.

Masanori Okuda (M)

Department of Cardiology, Hyogo Prefectural Awaji Medicine Center, 1-1-137, Shioya, Sumoto-shi, Hyogo 656-0021, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH